Riu Yamashita

Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.

Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.

Journal: JCO precision oncology

Published: July 01, 2026

AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC.

AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC.

Journal: International journal of clinical oncology

Published: June 14, 2026

The Q-MONSTAR consortium: advancing fault-tolerant quantum computing for precision oncology.

The Q-MONSTAR consortium: advancing fault-tolerant quantum computing for precision oncology.

Journal: Nature medicine

Published: April 21, 2026

SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.

SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.

Journal: International journal of clinical oncology

Published: February 12, 2026

Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab response.

Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab response.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: December 03, 2025

Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).

Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).

Journal: International journal of clinical oncology

Published: November 21, 2025

Hepatic-Differentiated Subpopulation in Clear Cell Renal Cell Carcinoma: A Multi-Omics Analysis of Tumors With Lymphovascular Invasion.

Hepatic-Differentiated Subpopulation in Clear Cell Renal Cell Carcinoma: A Multi-Omics Analysis of Tumors With Lymphovascular Invasion.

Journal: Cancer medicine

Published: November 11, 2025

Psychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing.

Psychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing.

Journal: Journal of human genetics

Published: November 05, 2025

Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection.

Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection.

Journal: NPJ precision oncology

Published: October 22, 2025

Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan.

Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan.

Journal: Cancer science

Published: September 29, 2025

Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Journal: Molecular cancer research : MCR

Published: August 27, 2025

JoGo 1.0: the ACTG hierarchical nomenclature and database covering 4.7 million haplotypes across 19,194 human genes.

JoGo 1.0: the ACTG hierarchical nomenclature and database covering 4.7 million haplotypes across 19,194 human genes.

Journal: Nucleic acids research

Published: August 15, 2025

Showing 1-12 of 75

Last Updated: 09/26/2026